1. Home
  2. SLNO vs MGEE Comparison

SLNO vs MGEE Comparison

Compare SLNO & MGEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • MGEE
  • Stock Information
  • Founded
  • SLNO 1999
  • MGEE 1855
  • Country
  • SLNO United States
  • MGEE United States
  • Employees
  • SLNO N/A
  • MGEE N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MGEE Electric Utilities: Central
  • Sector
  • SLNO Health Care
  • MGEE Energy
  • Exchange
  • SLNO Nasdaq
  • MGEE Nasdaq
  • Market Cap
  • SLNO 3.8B
  • MGEE 3.3B
  • IPO Year
  • SLNO 2014
  • MGEE N/A
  • Fundamental
  • Price
  • SLNO $86.00
  • MGEE $83.96
  • Analyst Decision
  • SLNO Strong Buy
  • MGEE Sell
  • Analyst Count
  • SLNO 9
  • MGEE 1
  • Target Price
  • SLNO $105.11
  • MGEE $74.00
  • AVG Volume (30 Days)
  • SLNO 1.5M
  • MGEE 162.3K
  • Earning Date
  • SLNO 08-06-2025
  • MGEE 08-11-2025
  • Dividend Yield
  • SLNO N/A
  • MGEE 2.14%
  • EPS Growth
  • SLNO N/A
  • MGEE 6.51
  • EPS
  • SLNO N/A
  • MGEE 3.54
  • Revenue
  • SLNO N/A
  • MGEE $687,578,000.00
  • Revenue This Year
  • SLNO N/A
  • MGEE $10.77
  • Revenue Next Year
  • SLNO $506.77
  • MGEE $3.48
  • P/E Ratio
  • SLNO N/A
  • MGEE $23.74
  • Revenue Growth
  • SLNO N/A
  • MGEE 6.11
  • 52 Week Low
  • SLNO $41.50
  • MGEE $82.21
  • 52 Week High
  • SLNO $90.32
  • MGEE $109.22
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 54.38
  • MGEE 37.90
  • Support Level
  • SLNO $83.53
  • MGEE $82.21
  • Resistance Level
  • SLNO $89.12
  • MGEE $86.71
  • Average True Range (ATR)
  • SLNO 2.65
  • MGEE 1.99
  • MACD
  • SLNO -0.34
  • MGEE -0.21
  • Stochastic Oscillator
  • SLNO 56.91
  • MGEE 24.01

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About MGEE MGE Energy Inc

MGE Energy provides electric service to 161,000 customers and natural gas service to 173,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings. MGE's generation mix is 40% coal, 21% renewable energy, 17% natural gas, and third-party purchased power.

Share on Social Networks: